Molecular Engineering of Glycoaptamer Dual-Target Radionuclide Probes for PET/CT Imaging of Triple-Negative Breast Cancer
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.5c00285 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Deyi Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Shanghai University, Shanghai 200444, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Positron Emission Tomography Computed Tomography, Aptamers, Nucleotide. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, National Key Research and Development Program of China, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is one of the most malignant cancer types, characterized by a lack of efficient diagnostic and treatment methods in clinical practice. The development of effective targeted diagnosis and treatment for TNBC has become an important research focus. Here, we report the first proof-of-concept evidence of a glycoaptamer dual-target radionuclide probe (GDRP) for positron emission tomography/computed tomography (PET/CT) imaging of TNBC. The GDRP was created through precise molecular engineering of the aptamer AS1411, combined with three mannose ligands. The GDRP exhibited significantly increased serum stability and a high affinity for TNBC cells through a dual targeting mode. The advantages of our developed GDRP were further demonstrated by its excellent in vivo PET/CT dynamic imaging performance, featuring a long imaging window and high spatiotemporal resolution. This flexible method allows for the preparation of glycosylated functional nucleic acid molecular probes with high serum stability and tumor specificity. We anticipate that this PET/CT molecular probe will expand the development of glycoaptamer-based radioactive drugs and provides molecular tools for the clinical diagnosis of TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Shanghai University, Shanghai 200444, China.
- Institute of Molecular Medicine, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit…
- Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
- Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), The Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
ORCID-Profile: Ding-Kun Ji
Förderung
- Natural Science Foundation of Shanghai Municipality
- National Key Research and Development Program of China
- Science and Technology Commission of Shanghai Municipality
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine
Zitieren
APA
Zhao, D., Han, Y., Chen, Y., He, Z., Xia, Q., Ji, D. K., & Tan, W. (2025). Molecular Engineering of Glycoaptamer Dual-Target Radionuclide Probes for PET/CT Imaging of Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c00285
Vancouver
Zhao D, Han Y, Chen Y, He Z, Xia Q, Ji DK, et al. Molecular Engineering of Glycoaptamer Dual-Target Radionuclide Probes for PET/CT Imaging of Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c00285
BibTeX
@article{Zhao2025,
author = {Zhao, Deyi and Han, Yongqi and Chen, Yamei and He, Zhenyang and Xia, Qian and Ji, Ding-Kun and Tan, Weihong},
title = {Molecular Engineering of Glycoaptamer Dual-Target Radionuclide Probes for PET/CT Imaging of Triple-Negative Breast Cancer},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.5c00285}
}
EUVIMED